Getting Started with Multiplex Fluorescence Image Analysis in HALO®
11 June 2025 | Learn the basics of multiplex fluorescence image analysis!
Getting Started with Multiplex Fluorescence Image Analysis in HALO® Read More »
Highplex FL
Masterclass Webinar: Performing Highly Multiplexed IF and Spatial Analysis Workflows with HALO®
25 June 2024 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform focused on highly multiplexed immunofluorescence slides.
Multiplex Immunohistochemical Phenotyping of T cells in Primary Prostate Cancer
20 October 2022 | Join us for this 1-hour webinar to learn about an iterative chromogenic based Serial Stain workflow in HALO®
Multiplex Immunohistochemical Phenotyping of T cells in Primary Prostate Cancer Read More »
Panel discussion: Clustering analysis of highly multiplexed immunofluorescence assays analyzed with the HALO® image analysis platform
13 September 2022 | Join us for this 1.5-hour panel discussion on high dimensional clustering to learn about options for performing clustering analysis and for visualizing high dimensional HALO® Highplex FL data, such as UMAP and t-SNE.
Advanced Multiplex and Spatial Analysis Methods using HALO Data
9 June 2022 | In this 90-minute webinar, Learn about an open-source MIBI image analysis pipeline using HALO data and how to validate a multiplex fluorescence panel for deployment in a clinical setting
Advanced Multiplex and Spatial Analysis Methods using HALO Data Read More »
Optimizing quantitative analysis of highly multiplexed CODEX images in HALO
31 March 2022 | In this webinar, Dr. Noemi Kedei, a staff scientist at the Collaborative Protein Technology Resource core of the Center for Cancer Research (CCR) at the National Cancer Institute, will present a comprehensive CODEX workflow, from image acquisition to image processing and HALO image analysis. Dr. Kedei leads the core facility that provides this technology as service to CCR investigators, including project consultation and design, antibody panel customization, tissue staining and imaging, image processing, and data management. Since Dr. Kedei and team were an early adopter of the CODEX platform, they have acquired deep expertise in CODEX, having imaged hundreds of mouse and human fresh frozen and FFPE tissues in support of multiple NCI/CCR projects.
Optimizing quantitative analysis of highly multiplexed CODEX images in HALO Read More »
Tumor-specific tumor-resident cytotoxic T cells predict recurrence in stage III melanoma patients treated with adjuvant immunotherapy
20 January 2022 | In this 60-minute webinar, learn how HALO and HALO AI collaborate to perform tissue and cell segmentation, quantification of T-cell subsets in tumor regions, and spatial analysis .
2021 Masterclass: Deep Dive into AI-Based Nuclear Segmentation and Phenotyping Part II
04 November 2021 | Following up on our HALO 3.2 Masterclass: Deep Dive into AI-based Nuclear Segmentation and Phenotyping, in this Masterclass webinar with HALO 3.3, we will further delve into options for AI-based nuclear segmentation and phenotyping.
2021 Masterclass: Deep Dive into AI-Based Nuclear Segmentation and Phenotyping Part II Read More »
THYROID MALT LYMPHOMA: SELF-HARM TO GAIN POTENTIAL T-CELL HELP
28 October 2021 | The development of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) is driven by chronic inflammatory responses and acquired genetic changes. To investigate its genetic bases, we performed targeted sequencing of 93 genes in 131 MALT lymphomas including 76 from the thyroid. We found frequent deleterious mutations of TET2 (86%), CD274 (53%), TNFRSF14 (53%) and TNFAIP3 (30%) in thyroid MALT lymphoma.
THYROID MALT LYMPHOMA: SELF-HARM TO GAIN POTENTIAL T-CELL HELP Read More »
Automated detection and quantitation of gastric immune cells in a mouse model of Helicobacter pylori-driven preneoplastic progression
21 October 2021 | Gastric cancer is the fourth-leading cause of cancer death worldwide. About 80% of cases are attributable to infection with the bacterium Helicobacter pylori (Hp). Untreated Hp infection causes lifelong stomach inflammation that does not eradicate the bacterium. In some individuals, stomach inflammation leads to preneoplastic progression, a series of sequential tissue changes including loss of gastric acid-producing parietal cells, metaplasia, dysplasia, and finally cancer.